Digital twins in Clinical trials: a new way of designing studies
In the past year, Digital twin has become one of the most overused terms in healthcare innovation. It appears in conference slides, CRO strategy decks, and investor presentations, often described as a virtual copy of a patient, ready to be tested like an avatar in a simulation. But the reality is less cinematic and far…
Patients are evolving faster than trials: why clinical data are falling behind
In clinical research, we speak often about patient-centricity. Yet in the past two years something unexpected has happened: patients’ real lives have become more digital, more monitored, and more interconnected than the trials designed to study them. The patient has changed.Their data pathways have not. Not because the industry lacks intent, but because traditional study…
PMS and Real-World Data: when real evidence begins after the study
When a clinical study changes its nature For a long time, post-market was treated as a phase that comes after the study.A necessary surveillance activity, but separate from clinical research itself. Today, that approach no longer works. Medical devices, especially digital and connected ones, continue to generate data long after the last patient visit.And that…
